NeuBase Therapeutics, Inc.
NasdaqCM:NBSE
$ 0.38
$0.00 (0.00%)
$ 0.38
$0.00 (0.00%)
End-of-day quote: 05/13/2024

NBSE - NeuBase Therapeutics Stock Prediction 2025 - 2030

5 years of reliable NeuBase Therapeutics stock forecast. The Wall Street analysts predict Data Unavailable for NBSE. See at a glance whether NasdaqCM:NBSE will rise in the future.

$0.00
Forecast 2023
$0.44
Forecast 2025
$0.75
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$0.44
Forecast 2030
$0.75
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.94
Price-to-book Ratio
0.04
Market Cap
0.00B
TEV
-0.00 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$200.00

NeuBase Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

NeuBase Therapeutics Stock Forecast 2023

$0.00

In the last five quarters, NeuBase Therapeutics’s Price Target has risen from $200.00 to $200.00 - a 0% increase. One analysts predict that NeuBase Therapeutics’s share price will fall in the coming year, reaching $0.00. This would represent a decrease of -100%.

-100%
-100
Last update: 05/14/2024

Highest Price Target $0.00

Average Price Target $0.00

Lowest Price Target $0.00

NeuBase Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One NeuBase Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $0.41. An increase of 8.12% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $0.41. An increase of 9.09% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $0.42. An increase of 10.06% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $0.42. An increase of 11.03% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $0.43. An increase of 12.01% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $0.43. An increase of 12.98% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $0.43. An increase of 13.95% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $0.44. An increase of 14.92% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $0.44. An increase of 15.89% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $0.44. An increase of 16.98% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $0.45. An increase of 18.06% compared to today's share price.

Stock Prediction for the Price of One NeuBase Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $0.45. An increase of 19.14% compared to today's share price.

NeuBase Therapeutics Stock Predictions 2030

NeuBase Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $0.70. An increase of 83.75% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $0.70. An increase of 85.4% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $0.71. An increase of 87.06% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $0.72. An increase of 88.71% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $0.72. An increase of 90.36% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $0.73. An increase of 92.01% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $0.74. An increase of 93.66% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $0.74. An increase of 95.31% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $0.75. An increase of 96.97% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $0.76. An increase of 98.8% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $0.76. An increase of 100.64% compared to the previous month's estimate.

NeuBase Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $0.77. An increase of 102.48% compared to the previous month's estimate.

P/E
0.00
Beta
0.94
Price-to-book Ratio
0.04
Market Cap
0.00B
TEV
-0.00 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$200.00

NeuBase Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching NeuBase Therapeutics, Inc.?

The following analysts have recently covered NeuBase Therapeutics:

Data Unavailable
(This information refers to the last 90 days.)

Who are the sell-side analysts watching NeuBase Therapeutics, Inc.?

The following sell-side analysts have recently covered NeuBase Therapeutics:

Data Unavailable
(This information refers to the last 90 days.)